Presentation is loading. Please wait.

Presentation is loading. Please wait.

Renal Insufficiency.

Similar presentations


Presentation on theme: "Renal Insufficiency."— Presentation transcript:

1 Renal Insufficiency

2 “To be a great champion you must believe you are the best
“To be a great champion you must believe you are the best. If you’re not, pretend you are….!” – Muhammad Ali

3 TOPICS Introduction Acute renal failure Chronic renal failure Uremia

4 Functions of kidney The kidneys are a pair of small organs that lie on either side of your spine at about waist level. They act as filters that keep your blood free of by-products and toxins. The kidneys excrete these compounds with water to make urine. They also eliminate excess body water while selectively reabsorbing useful chemicals and allowing waste to pass freely into the bladder as urine. They allow you to continue to consume a variety of foods, drugs, vitamins and supplements, additives, and excess fluids without worry that toxic by-products will build up to harmful levels.

5 The kidneys play an essential role in maintaining electrolyte and acid-base balance.
They produce some hormones including renin, prostaglandins, erythropoietin, and active vitamin D. So, they are crucial in the regulation of blood pressure, formation of matured red blood cells, and metabolism of calcium and phosphorus.

6 Functions of the Kidney
Waste excretion Electrolyte balance Fluid balance pH Osmolality Hormone production

7 Anatomy of Kidney

8

9 Manifestation of renal dysfunction
Glomerulus · decreased GFR · glomerular filtration membrane permeability alteration Renal tubule · concentrative function decline (hyposthennuria/isosthennuria) · water, electrolyte, acid-base disorder · others Endocrine disorder · hypertension · anemia · renal osteodystrophy

10 体内VitD3的代谢过程 紫外线 25-羟化酶 1α-羟化酶
紫外线 羟化酶 α-羟化酶 7-脱氢胆固醇 VitD (OH)VitD ,25-(OH) 2VitD3 (皮肤) (肝微粒体) (肾线粒体)

11 Acute Renal Failure, ARF

12 Etiology & classification Prerenal failure
Definition Etiology & classification Prerenal failure Intrinsic renal failure Post(obstructive) renal failure Pathogenesis Clinical manifestation Therapy

13 Definition Acute renal failure (ARF) is defined as a precipitous and significant (>50%) decrease in glomerular filtration rate (GFR) over a period of hours to days, with an accompany-ing accumulation of nitrogenous wastes in the body.

14 急性肾功能衰竭的定义 肾泌尿功能障碍表现为GFR迅速下降,出现少尿无尿;内环境紊乱主要表现为氮质血症、高钾血症和代谢性酸中毒。
 急性肾功能衰竭(acute renal failure,ARF)是指各种病因引起双侧肾脏在短期内泌尿功能急剧降低,导致机体内环境出现严重紊乱的病理过程和临床综合症。 肾泌尿功能障碍表现为GFR迅速下降,出现少尿无尿;内环境紊乱主要表现为氮质血症、高钾血症和代谢性酸中毒。 急性肾功能衰竭根据尿量减少与否,分为少尿型(成人每日尿量少于400ml)和非少尿型(成人每日尿量大于400ml)两种类型。急性肾衰病情凶险,临床较常见,但若及时诊治,预后较好。

15 Etiology Pre-renal (~70% of cases) Intrinsic-renal (~25% of cases)
resulting from impaired blood flow to or oxygenation of the kidneys. Intrinsic-renal (~25% of cases) resulting from injury to or malformation of kidney tissues. Post-renal (<5% of cases) resulting from obstruction of urinary flow between the kidney and urinary meatus.

16 Causes Prerenal failure - Diseases that compromise renal perfusion
Decreased effective arterial blood volume - Hypovolemia, CHF, liver failure, sepsis Renal arterial disease - Renal arterial stenosis (atherosclerotic, fibromuscular dysplasia), embolic disease (septic, cholesterol)

17 休克的原因(失血、失液、感染、急性心衰、
肾前性因素 休克的原因(失血、失液、感染、急性心衰、 严重过敏反应)和其它(肝肾综合征) ADH 有效循环血量 Ald 血压降低 肾灌流压 肾血管收缩   肾血流量   肾小球有效滤过压   GFR 尿量 肾前性急性肾功能衰竭的发生机制

18 Intrinsic renal failure - Diseases of the renal parenchyma, specifically involving the renal tubules, glomeruli, interstitium ATN, ischemia, toxins (eg, aminoglycosides, radiocontrast, heme pigments, cisplatin, myeloma light chains, ethylene glycol) Interstitial diseases - Acute interstitial nephritis, drug reactions, autoimmune diseases (eg, systemic lupus erythematosus [SLE]), infiltrative disease (sarcoidosis, lymphoma), infectious agents (Legionnaire disease, hantavirus) Acute glomerulonephritis Vascular diseases - Hypertensive crisis, polyarteritis nodosa, vasculitis

19 Postrenal failure - Diseases causing urinary obstruction from the level of the renal tubules to the urethra Tubular obstruction from crystals (eg, uric acid, calcium oxalate, acyclovir, sulfonamide, methotrexate, myeloma light chains) Ureteral obstruction - Retroperitoneal tumor, retroperitoneal fibrosis (methysergide, propranolol, hydralazine), urolithiasis, papillary necrosis Urethral obstruction - Benign prostatic hypertrophy; prostate, cervical, bladder, colorectal carcinoma; bladder hematoma; bladder stone; obstructed Foley catheter; neurogenic bladder.

20 Causes of ARF in tertiary care hospital setting

21 急性肾功能衰竭病因与分类 肾前性ARF (早期为功能性ARF ) 肾性ARF(亦称器质性ARF) 肾后性ARF
由肾脏实质病变引起。急性肾小管坏死(acute tubular necrosis,ATN)是临床上最常见、最重要的ARF类型,约占ARF的75%~80% 。 肾后性ARF 因双侧性尿路梗阻引起,如尿路结石、肿瘤、前列腺疾患等。

22 Pathogenesis of ARF I. Renal hemodynamics factors
Decreased renal blood flow Renal hypoperfusion Vasoconstriction Vascular obstruction Redistribution of renal blood flow

23 II. Nephronal factors Tubule injury Tubule obstruction
Passive backflow

24 Acute Renal Failure, Intrinsic Acute Tubular Necrosis
Renal hypoperfusion/ischemia Nephrotoxic agents (both endogenous and exogenous) Mortality 50% Bronchopulmonary infections, sepsis, cardiovascular disease, bleeding disorders Complete Recovery 25%, Incomplete 20%, No Recovery 5%

25 Acute Tubular Necrosis Nephrotoxic Agents
Exogenous Antibiotics Contrast Diuretics Chemotherapeutics Analgesics Solvents, metals, chemicals HIV meds Antiulcer meds Anesthetics Endogenous Pigment nephropathy Crystal deposition Tumor-specific syndromes

26 Acute Tubular Necrosis
Cell Hypoxia Depletion of ATP Hypoxanthine Impaired function Of plasma membranes And ATPases Ca++ imbalance Na-K imbalance Cell Swelling Disrupt cytoskeleton Activate phospholipases Formation of xanthine oxidase Uncoupling of oxidative phosphorylation Disrupt lipid bilayer Reperfusion injury Free radicals

27 Acute Tubular Necrosis
Leads to… Loss of cell polarity Brush border loss Impaired cell-cell adhesion Impaired tight junction End results… Impaired solute and water transport Sloughing of tubule cells  obstruction Back leakage of filtrate

28 急性肾功能衰竭的发病机制 急性肾衰发病机制的中心环节是GFR的降低。 一 肾血流动力学异常 二 肾小管损伤 三 肾小球超滤系数降低
一 肾血流动力学异常 肾血流急剧减少 肾灌注压下降 肾血管收缩 肾血管阻塞 肾内血流重分布 二 肾小管损伤 肾小管阻塞 原尿返流 三 肾小球超滤系数降低

29 Characteristics & clinical courses
Oliguric phase Diuretic phase Recovery phase

30 Oliguric phase Usually lasting for 1 to 6 weeks,the average duration is between 7 & 10 days. Features of urine: I. Oliguria or Anuria II. Hematuria and casts III. Low specific gravity and osmolality IV. Urinary [Na+] above 20mM Azotemia Metabolic acidosis Hyperkalemia Hypervolemia / Hypertension Others: edema, water intoxication,tachypnea

31 Urine specific gravity
Urinary Indices in ARF Prerenal ARF ATN Urinary [Na+], mEq/L <20 >40 Urine to plasma Cr Urine osmolality >500 <400 Urine specific gravity >1.020 <1.015 Renal Failure Index <1 >1 FENa Response to IVF Good Poor

32 功能性肾衰和器质性肾衰(ATN)的鉴别 功能性肾衰 器质性肾衰 尿液性质 尿比重 治疗与反应 尿渗透压 尿钠
功能性肾衰 器质性肾衰 尿液性质 尿比重 尿渗透压 尿钠 尿肌酐/血肌酐 尿常规 治疗与反应 > <1.015 >500mOsm/L <400mOsm/L <20mmol/L >40mmol/L > <20 正常 蛋白尿、管型、红细胞、白细胞 应迅速补充血容量 需严格控制补液量 使肾血流恢复,GFR 量出而入 补液后 尿量迅速增多 尿量持续减少 病情明显好转 甚至使病情恶化

33 Muddy Brown Cast

34 Red Cell Cast

35 White Cell Casts

36 Diuretic phase Recovery phase
As healing begins, improvement is reflected in the production of more than 400 ml of urine per day. Fluid and electrolyte abnormalities. Cr may still rise for 1-2 more days. Recovery phase

37 ARF的主要机能代谢变化和临床表现 一 少尿期
1. 少尿、无尿 2. 氮质血症:指肾功能衰竭时,由于GFR下降,含氮的代谢产物如尿素、肌酐、尿酸等在体内蓄积,引起血中非蛋白氮的含量增加(>28.6mmol/L,或>40mg/dl)。 3. 水中毒:当肾排水功能障碍的情况下,一旦水摄入稍多,就易造成稀释性低钠血症,大量水份进入细胞内,引起脑水肿、肺水肿、心力衰竭。因此对少尿期ARF患者,要严格控制摄入水量。 4. 高血钾:主要由GFR降低和肾小管泌钾障碍引起,机体代谢分解增强使钾释放增多及酸中毒引起细胞内钾向细胞外转移,都能促使血钾进一步增高。严重高血钾可导致室颤和心跳骤停。高钾血症是ARF患者第一周死亡的最常见原因。 5. 代谢性酸中毒:主要由GFR降低、肾小管排酸保碱作用减退、体内分解代谢加强使固定酸产生过多等原因引起。

38 二 多尿期 经过少尿期后,当每天尿量大于400ml,说明病人已进入多尿期。进行性尿量增多是肾功能开始恢复的一个标志。多尿期的早期,GFR仍较正常为低,主要因肾小管修复再通而修复的肾小管浓缩功能仍很差,一方面排出代谢产物的能力不足,一方面出现多尿。这时患者仍可存在氮质血症,也可能存在高钾血症。尿量过多常使患者发生水、电解质紊乱,主要倾向是脱水、低血钾和低血钠,所以对这些病人要注意预防。 三 恢复期 患者自我感觉好转,逐步能自理生活和进行劳动。尿量逐渐恢复正常,血尿素氮和肌酐也接近正常。

39 Nonoliguric acute renal failure
非少尿型ARF近年来有逐渐增多的趋势;这可能与病人医疗意识加强、医疗诊治手段提高及肾毒性抗生素广泛应用有关。其机制为:① 不同肾单位受损程度不一,小部分肾单位的肾血流量和肾小球滤过功能存在;② 肾小管重吸收功能障碍远较肾小球滤过功能降低为重;③ 肾髓质形成高渗状态的能力降低,使尿液浓缩功能下降,故发病后尿量无明显降低,在400~1000 ml/d左右。非少尿型ARF较少尿型ARF病情轻、预后好,但因症状轻而不太明显,容易延误病人的就诊或引起医生的漏诊。非少尿型ARF不及时治疗,则会转化为少尿型ARF。

40 Management Renal Diet Acidosis Hyperuricemia Hypertension
Volume overload Protein Load Newer Agents:ANF Dialysis Kidney Transplantation Hospital inpatients with ARF ~50% mortality rate

41 Dialysis indications I. Serum abnormalities unresponsive to medical therapy Severe Acidosis Severe Hyperkalemia II. Uremia Mental status changes (usually delirium) Nausea and vomiting Pericarditis (pericardial friction rub) III. Volume Overload

42 Peritoneal Dialysis

43 Hemodialysis Blood is circulated through artificial cellophane membrane that permits a similar passage of water and solutes

44 Chronic Renal Failure, CRF

45 Definition Etiology Pathogenesis Clinical manifestation Therapy

46 Definition Chronic renal failure (CRF) is defined as a permanent reduction in glomerular filtration rate (GFR) sufficient to produce detectable alterations in well-being and organ function. This usually occurs at GFR below 25 ml/min.

47 CRF is characterized by progressive and irreversible loss of large numbers of functioning nephrons. Serious clinical symptoms often do not occur until the number of functional nephrons falls to at least 70 per cent below normal. In fact relatively normal blood concentrations of most electrolytes and normal body fluid volumes can still be maintained until the number of functioning nephrons decreases below 20-30percent of normal.

48

49 慢性肾功能衰竭的定义 慢性肾功能衰竭是由于各种肾脏疾病引起肾单位进行性破坏,以致残存的有功能的肾单位不能充分排出代谢废物和维持内环境恒定的缓慢发展的一种肾功能损害的病理过程。机体逐渐出现代谢废物和毒物的潴留,水、电解质与酸碱平衡紊乱,以及肾内分泌功能障碍,并可伴有全身各系统功能受损的临床症状。 因为肾组织的破坏是逐渐发生的,而且肾脏又有较强的代偿能力,故慢性肾衰常常是缓慢发展,病程迁延数月、数年以至更长的时间,最后常导致尿毒症而死亡。尿毒症是指急、慢性肾功能衰竭最危重的阶段。

50 Causes of CRF Any disorder that permanently destroys nephrons can result in chronic renal failure. Most common causes of CRF are: Diabetic nephropathy Hypertensive nephrosclerosis Glomerulonephritis Interstitial nephritis Polycystic kidney disease

51 慢性肾功能衰竭的病因 凡能引起肾实质进行性破坏的疾患,均可引起慢性肾功能衰竭。其中以慢性肾小球肾炎为最常见,约占CRF的50%~60%。
(1)肾脏疾患:慢性肾小球肾炎、慢性肾盂肾炎、肾结核、肾肿瘤、全身性红斑狼疮。 (2)肾血管疾患:高血压肾小动脉硬化等。 (3)尿路慢性梗阻:尿路结石、前列腺肥大等。 (4)全身代谢性疾病:糖尿病肾病等。 (5)其他:药物性肾损伤等。

52 Clinical courses of CRF
Four stages of decreased renal function may be visualized: Silent – GFR up to 50 ml/min. Renal insufficiency – GFR 25 to 50 ml/min. Renal failure – GFR 5/10 to 25 ml/min End-stage renal failure (ESRF) – GFR less than 5/10 ml/min.

53 Stages of Chronic Kidney Disease
Description GFR Level Normal kidney function Healthy kidneys 90 mL/min or more Stage 1 Kidney damage with normal or high GFR Stage 2 Kidney damage and mild decrease in GFR 60 to 89 mL/min Stage 3 Moderate decrease in GFR 30 to 59 mL/min Stage 4 Severe decrease in GFR 15 to 29 mL/min Stage 5 Kidney failure Less than 15 mL/min or on dialysis

54 慢性肾功能衰竭的发展过程和分期 内生肌酐清除率 氮质血症 临床表现 (ml/min) 代偿期 >50 无 无任何症状。但不能负荷额
内生肌酐清除率 氮质血症 临床表现 (ml/min) 代偿期 > 无 无任何症状。但不能负荷额 外的水、电解质和酸碱 失代偿期 肾功能不全期 轻、中度 轻度消化道症状和贫血 肾功能衰竭期 较重 明显多尿、夜尿和水、电解 质、 酸碱紊乱 尿毒症期 < 严重 全身中毒症状明显,各脏器 系统功能障碍

55 Pathogenesis The most intriguing aspect of CRF is that compensatory mechanisms allow loss of 90% of GFR before manifestations of the uremic syndrome are evident. Thus a variety of adaptations compensate for the decreased GFR and allow a new steady state of external balance to exist, but on the other hand contribute to the uremic syndrome. In spite of these adaptations, the hallmark of CRF is the loss of flexibility in responding to challenges to external load of solutes and water. Intact Nephron hypothesis Tubulointerstitial cell injury Trade-off hypothesis

56 Intact Nephron Hypothesis
Nephrons functioning in diseased kidneys maintain glomerulo-tubular balance. That is, filtration and net excretion of various substances are coordinated. (e.g. with normal renal function, usually 50-60% of filtered urea is reabsorbed from the tubules. In CRF it may fall to 30% to maintain balance).

57 The Magnification Phenomenon
although nephrons in diseased kidneys function homogeneously, they alter their handling of given solutes as needed to maintain balance of these solutes. That is, nephrons can magnify their excretion of a given solute. (e.g. tubular creatinine excretion is < 10% with normal renal function. In CRF it may increase to 30%).

58 Trade-off Hypothesis The mechanisms that are magnified to maintain individual solute control may have deleterious effects on other systems. This trade-off is seen in the increased parathyroid hormone (PTH) secretion seen in CRF which enhances renal phosphorus excretion. PTH has been implicated in the pathogenesis of many disturbances of uremia (sleep, sex, bone, disease, anemia, lipidemia, vascular disease). As renal disease progresses and GFR decreases, high level PTH no longer maintains the phosphate excretion. The excessive PTH may result in further side effects, such as osteomalacia, deposit of calcium phosphate salts into soft tissue and damage of cardiovascular, neural systems.

59 慢性肾功能衰竭的发病机制 健存肾单位进行性减少 矫枉失衡 肾小管 - 间质损害

60 钙磷代谢的矫枉失衡 慢性肾脏疾患 肾单位↓ GFR↓ GFR↓↓ VitD3 血磷↓ 肾排磷↓ 肾排磷↓↓ 酸中毒 肾排磷↑
肾单位↓ GFR↓ GFR↓↓ VitD3 血磷↓ 肾排磷↓ 肾排磷↓↓ 酸中毒 肾排磷↑ 血磷↑、血钙↓ 血磷↑↑   肾小管重吸收磷↓ PTH↑ 血钙↓↓ (健存肾单位) 血钙↑ 溶骨 肾性骨营养不良   “矫正” “失衡”

61 内生肌酐清除率Ccr = [ 尿肌酐 ]  尿量/分 [ 血肌酐 ] *正常值:90-140ml/min *无肌酐饮食2-3天后测定。
*无肌酐饮食:摄入蛋白质<40g/天,禁肉食,避免剧烈运动。

62 Clinical manifestations of CRF
Loss of nephron’s function to excrete water and solutes. Characteristics of urine: urine volume,osmotic & gravity, urinary sediment Effects on body fluids. water & sodium imbalance potassium imbalance metabolic acidosis phosphate & calcium metabolism dysfunction azotemia Other signs of CRF cardiovascular abnormalities anemia & bleeding renal osteodystrophy

63 Anemia Anemia is universal as GFR falls below 25 ml/min.; in certain disorders it may occur with mild renal insufficiency. Several factors contribute:  a. Erythropoiesis is markedly depressed, mainly due to reduced erythropoietin production; in addition, there may be reduced end-organ response to erythropoietin with reduced heme synthesis. b. Red cell survival is shortened with a mild to moderate decrease in red cell life span, possible due to a “uremic” toxin. c. Blood loss is common in uremic patients, possibly secondary to abnormal coagulation due to decreased platelet function. d. Marrow space fibrosis occurs with osteitis fibrosa of secondary hyperparathyroidism resulting in decreased erythropoiesis.

64 Hypertension   Hypertension occurs in 80% to 90% of patients with renal insufficiency. Several factors contribute: a. Expansion of extracellular fluid volume; this may arise because of reduced ability of the kidney to excrete ingested sodium. b. Increased activity of the renin-angiotensin system is common; many patients with advanced renal failure have renin levels that are not completely suppressed by the elevated blood pressure. c. Dysfunction of the autonomic nervous system occurs with insensitive baroreceptor sensitive and with increased sympathetic tone. d. Possible diminished presence of vasodilators: there may be decreased renal generation of prostaglandins or of factors in the kallikrein-kinin system.

65 Altered Calcium and Phosphorus Metabolism (Renal Osteodystrophy)
 a. As GFR decreases there is a slight retention of phosphorus; this phosphorus retention can lead to hypocalcemia, which stimulates PTH. The latter causes phosphaturia, with restoration of serum phosphorus and calcium toward normal. However, this occurs only at the expense of elevated serum PTH levels. This cycle repeats itself in progressive renal failure with PTH levels increasing progressively. Ultimately, the renal tubule can no longer respond to higher levels of PTH with a further decrease in phosphorus reabsorption. When this occurs, hyperphosphatemia develops, hypocalcemia may become prominent and PTH level can increase to very high levels. High PTH levels cause bone disease with severe osteitis fibrosa. b. Altered vitamin D metabolism occurs secondary to decreased renal mass or to phosphate retention, with decreased synthesis of 1,25 (OH)2 D3. This deficiency leads to: 1. Diminished intestinal absorption of calcium, 2. decreased calcemic response of the skeleton to PTH, 3. impaired suppression of PTH secretion for any increase in serum calcium level, and 4. altered collagen synthesis. With advanced renal failure, these events can lead to secondary hyperparathyroidism and osteomalacia. c. Skeletal resistance to the calcemic action of PTH develops; thus an increased PTH is required to maintain serum calcium at any level. d. Finally, accumulation of aluminum from aluminum binding antacids may contribute to the bone disease.

66 慢性肾功能衰竭的功能代谢变化 1.泌尿功能障碍 2.氮质血症 3.水、电解质和酸碱平衡紊乱
尿量的变化:早期:夜尿、多尿;晚期:少尿。 尿渗透压的变化:低渗尿、低比重尿→等渗尿。 尿质的变化:尿中可出现蛋白尿、红细胞、白细胞、管型等。 2.氮质血症 3.水、电解质和酸碱平衡紊乱 机体对水、钠、钾的调节能力下降,并可出现高磷、低钙血症。由于肾脏排酸保碱功能降低,可发生代谢性酸中毒。 4.肾性高血压(renal hypertension) 5.肾性贫血(renal anemia) 6.出血倾向 7.肾性骨营养不良

67 慢性肾功能衰竭引起高血压的机制 GFR↓ 肾血液灌流量↓ 肾实质破坏 钠水排出↓ 肾素分泌↑
肾脏疾病 GFR↓ 肾血液灌流量↓ 肾实质破坏 钠水排出↓ 肾素分泌↑ 钠水潴留 Ald↑ 血管紧张素II↑ 肾髓质细胞 PGA2、PGE2生成↓ 血容量↑ 外周阻力↑ 心输出量↑ 高血压

68 肾性骨营养不良的发生机制 慢性肾功能衰竭 1,25-(OH)2VitD3 GFR↓ 肠钙吸收↓ 排磷↓ 低钙血症 高磷血症 酸中毒
  慢性肾功能衰竭 1,25-(OH)2VitD GFR↓ 肠钙吸收↓ 排磷↓ 低钙血症 高磷血症 酸中毒 骨质钙化障碍 PTH分泌↑   骨盐溶解↑ 骨质脱钙   肾性骨营养不良

69 Uremia

70 Concept Uremia, from the Greek “urine in the blood”, is a clinical and biochemical syndrome that occurs either abruptly or gradually as renal function decreases acutely or chronically. In its extreme expression as uremic coma, the patient behaves as if poisoned, hypothermia, intermittent seizures, a bleeding diathesis,cardiac arrhythmias, vomiting, and rapid, shallow respirations may appears.

71 Uremia Definition: symptomatic azotemia Acidosis (± tachypnea)
Mental Status changes Hypervolemia / Hypertension Hyperkalemia Pericarditis

72 尿毒症 急性或慢性肾功能衰竭晚期,病人体内水电解质、酸碱平衡紊乱,肾脏内分泌功能失调,大量代谢产物和毒性物质蓄积,从而引起一系列全身中毒症状,称为尿毒症(uremia)。尿毒症是急性或慢性肾功能衰竭的最严重和最后阶段。

73 Clinical Manifestations
The symptoms and signs which constitute the uremic syndrome are summarized below: Neurological Disorders: Fatigue, lethargy, sleep disturbances, headache, seizures, encephalopathy, peripheral neuropathy including restless leg syndrome, paraesthesia, motor weakness, paralysis. Hematologic Disorders: Anemia, bleeding tendency – due in part to platelet dysfunction. Cardiovascular Disorders: Pericarditis, hypertension, congestive heart failure, coronary artery disease, myocardiopathy. Pulmonary Disorders: Pleuritis, uremic lung. Gastrointestinal Disorders: Anorexia, nausea, vomiting gastroenteritis, GI bleeding, peptic ulcer.

74 Metabolic-Endocrine Disorders: Glucose intolerance, hyperllipidemia, hyperuricemia, malnutrition, sexual dysfunction and infertility. Bone, Calcium, Phosphorus Disorders: Hyperphosphatemia, hypocalcemia, tetany, metastatic calcification, secondary hyperparathyroidism, 1,25-dihydroxy vitamin D deficiency, osteomalacia, osteitis fibrosa, osteoporosis, osteosclerosis. Skin Disorders: Pruritus, pigmentation, easy bruising, uremic frost. Psychological Disorders: Depression, anxiety, denial, psychosis. Fluid and Electrolyte Disorders: Hyponatremia, hyperkalemia, hypermagnesemia, metabolic acidosis, volume expansion or depletion

75 Principles of treatment for CRF & Uremia
Conservative management Dialysis Peritoneal dialysis Hemodialysis Renal transplantation

76 case 某8岁患儿因感染采用磺胺嘧啶治疗,因使用剂量过大,用药5天后,连续3日尿量少于100ml/d,急诊入院。经查:血肌酐480μmol/L(正常值为<178μmol/L),尿钠 100mmol/L(正常值为<20mmol/L),尿相对密度 1.008。问:该病人是否发生了肾功能衰竭?如果是,是急性肾功能衰竭,还是慢性肾功能衰竭?该病人的尿少是肾前性因素、肾性因素还是肾后性因素所致?为什么血肌酐、尿钠浓度增高?为什么尿相对密度降低?

77 Treatment of end stage renal failure(ESRF)
When GFR falls below 5 ml/min, the patient usually can not live without renal replacement therapy. Renal replacement therapy includes dialysis and kidney transplantation . Various social or medical factors influence decisions about peritoneal or hemodialysis, and transplantation in the treatment of end-stage renal failure. It should also be noted that none of the above are panaceas and each, modality is associated with complications and failures.

78 Azotemia - elevated blood urea nitrogen (BUN >28mg/dL) and creatinine (Cr>1.5mg/dL)
Uremia - azotemia with symptoms or signs of renal failure End Stage Renal Disease (ESRD) - uremia requiring transplantation or dialysis Chronic Renal Failure (CRF) - irreversible kidney dysfunction with azotemia >3 months Creatinine Clearance (CCr) - the rate of filtration of creatinine by the kidney (GFR marker) Glomerular Filtration Rate (GFR) - the total rate of filtration of blood by the kidney

79 The End

80 肾小球滤过率 (glomerural filtration rate,GFR)
肾小球滤过面积 肾小球有效滤过压 = 肾小球毛细血管血压 – 血浆胶体渗透压 – 肾小球囊内压 肾血流量

81 Glomerular Filtration Rate
GFR = Kf [(Pgc-PB) - (Πgc-ΠB)] = Kf (ΔP-ΔΠ) Kf = glomerular ultrafiltration coefficient Pgc = glomerular capillary hydraulic pressure PB = Bowman’s space hydraulic pressure Πgc = glomerular colloid osmotic pressure ΠB = Bowman’s space colloid osmotic pressure

82 Estimates of GFR Inulin neither secreted or reabsorbed
Clearance of inulin approximates GFR [U]inulin V [P]inulin Creatine is secreted, so Cr clearance overestimates GFR GFR =

83 Estimates of GFR CrCl = CrCl = Urinary Estimate [U]cr V [P]cr
Cockcroft Gault Estimate [140-age (yr)][body wt (kg)] 72[Pcr] CrCl = CrCl =

84 Glomerulus

85

86 Filtration Membrane – Electron Micro.
Capillary Space GBM Endothelium Urinary Space Podocyte

87

88 Symptoms of chronic kidney disease
Fatigue and weakness (from anemia or accumulation of waste products in the body)   Loss of appetite, nausea and vomiting  Need to urinate frequently, especially at night Swelling of the legs and puffiness around the eyes (fluid retention) Itching, easy bruising, and pale skin (from anemia) Headaches, numbness in the feet or hands (peripheral neuropathy), disturbed sleep, altered mental status (encephalopathy from the accumulation of waste products or uremic poisons), and restless legs  High blood pressure, chest pain due to pericarditis (inflammation around the heart) Shortness of breath from fluid in lungs Bleeding (poor blood clotting) Bone pain and fractures Decreased sexual interest and erectile dysfunction


Download ppt "Renal Insufficiency."

Similar presentations


Ads by Google